T. Rowe Price Group Reports Preliminary Month-End Assets Under Management For December 2018

BALTIMOREJan. 11, 2019 /PRNewswire/ — T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) today reported preliminary month-end assets under management of $962 billion as of December 31, 2018. Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $1.9 billion in December 2018, and $3.7 billion for the quarter-ended December 31, 2018.  This brings total client transfers for 2018 to $20.5 billion.

The firm’s assets under management as of December 31, 2018, and for the prior month-, quarter-, and year-end, by investment vehicle, asset class, and in the firm’s target date retirement portfolios are as follows:

As of

Preliminary(a)

(in billions)

12/31/2018

11/30/2018

9/30/2018

12/31/2017

U.S. mutual funds

 Equity and blended assets

$

441

$

485

$

515

$

480

 Fixed income and money market

123

126

130

126

564

611

645

606

Subadvised and separately managed accounts and other investment products

 Equity and blended assets

299

323

339

292

 Fixed income and money market

99

98

100

93

398

421

439

385

Total assets under management

$

962

$

1,032

$

1,084

$

991

Target date retirement products(b)

$

230

$

243

$

252

$

234

(a) Preliminary – subject to adjustment

(b) Includes the assets under management of the firm’s target date retirement mutual funds and trusts as well as those target date retirement portfolios managed in separate accounts.

Founded in 1937, Baltimore-based T. Rowe Price (troweprice.com) is a global investment management organization that provides a broad array of mutual funds, subadvisory services, and separate account management for individual and institutional investors, retirement plans, and financial intermediaries. The organization also offers a variety of sophisticated investment planning and guidance tools. T. Rowe Price’s disciplined, risk-aware investment approach focuses on diversification, style consistency, and fundamental research.

SOURCE T. Rowe Price Group, Inc.

Related Links

http://www.troweprice.com

Leave a Reply

Your email address will not be published. Required fields are marked *